Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.40 is 180% above its 5-year average of -1.76, near the high end of its 5-year range (-3.19–1.40).
277.22% above its 12-month average of -0.79.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 1.20.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:52.642Z. Historical observations retain their original dates. Historical series through 2026-09-11.
EARNINGS PER SHARE (EPS)
1.40
EARNINGS PER SHARE (EPS) AVG TTM
-0.79
EARNINGS PER SHARE (EPS) AVG 3Y
-1.41
EARNINGS PER SHARE (EPS) AVG 5Y
-1.76
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+277.22%
CURRENT VS 3Y AVG
+199.12%
CURRENT VS 5Y AVG
+179.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Oscar Health, Inc.
Market Cap
$8.33B
Earnings Per Share (EPS)
1.40
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
Market Cap
$9.66B
Earnings Per Share (EPS)
3.43
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$9.99B
Earnings Per Share (EPS)
3.89
TTM Avg
2.37
3Y Avg
1.93
5Y Avg
1.71
Market Cap
$6.59B
Earnings Per Share (EPS)
19.92
TTM Avg
19.26
3Y Avg
18.34
5Y Avg
18.42
Market Cap
$10.13B
Earnings Per Share (EPS)
8.25
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$10.14B
Earnings Per Share (EPS)
6.38
TTM Avg
5.63
3Y Avg
4.78
5Y Avg
4.31
Market Cap
$6.24B
Earnings Per Share (EPS)
-0.63
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$10.48B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oscar Health, Inc. (OSCR) | $8.33B | 1.40 | -0.79 | -1.41 | -1.76 |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 3.43 | 3.18 | 3.37 | 3.47 |
| Insulet Corp. (PODD)vs › | $9.74B | 5.35 | 4.74 | 3.13 | 2.14 |
| Globus Medical, Inc. (GMED)vs › | $9.99B | 3.89 | 2.37 | 1.93 | 1.71 |
| Chemed Corporation (CHE)vs › | $6.59B | 19.92 | 19.26 | 18.34 | 18.42 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.13B | 8.25 | -18.74 | -45.28 | 14.90 |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 6.38 | 5.63 | 4.78 | 4.31 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | -0.63 | 0.57 | 0.18 | -0.06 |
| Molina Healthcare, Inc. (MOH)vs › | $10.48B | 0.19 | 14.72 | 15.46 | 14.11 |
| Align Technology, Inc. (ALGN)vs › | $10.57B | 5.76 | 5.64 | 5.43 | 9.01 |
Trailing EPS (TTM)
$1.40
Forward EPS (Est.)
$1.72
P/E Ratio
22.9
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.69 |
| 2024-12-31 | 0.11 |
| 2023-12-31 | -1.22 |
| 2022-12-31 | -2.85 |
| 2021-12-31 | -3.19 |
| 2020-12-31 | -1.70 |
| 2019-12-31 | -8.93 |
